R.S.V. Vaccines May Slightly Increase Risk of Rare Neurological Conditionnews2024-02-29T22:20:23+00:00February 29th, 2024|The New York Times|
FDA Approves Pfizer’s RSV Vaccine for Adults 60 and Oldernews2023-05-31T22:35:58+00:00May 31st, 2023|The New York Times|
FDA Panel Recommends 2 RSV Vaccines for Older Adultsnews2023-03-01T21:29:15+00:00March 1st, 2023|The New York Times|
F.D.A. Attaches Warning of Rare Nerve Syndrome to Johnson & Johnson Covid Vaccinenews2021-07-13T02:28:00+00:00July 13th, 2021|The New York Times|
